Abstract
Oxidative stress is associated with the development and progression of numerous diseases. However, targeting oxidative stress has not been established in the clinical management of any disease. Several methods and markers are available to measure oxidative stress, including direct measurement of free radicals, antioxidants, redox balance, and oxidative modifications of cellular macromolecules. Oxidatively generated nucleic acid modifications have attracted much interest due to the pre-mutagenic oxidative modification of DNA into 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodG), associated with cancer development. During the last decade, the perception of RNA has changed from that of a ‘silent messenger’ to an ‘active contributor’, and, parallelly oxidatively generated RNA modifications measured as 8-oxo-7,8-dihydro-guanosine (8-oxoGuo), has been demonstrated as a prognostic factor for all-caused and cardiovascular related mortality in patients with type 2 diabetes. Several attempts have been made to modify the amount of oxidative nucleic acid modifications. Thus, this review aims to introduce researchers to the measurement of oxidatively generated nucleic acid modifications as well as critically review previous attempts and provide future directions for targeting oxidatively generated nucleic acid modifications.
Original language | English |
---|---|
Journal | Free Radical Biology and Medicine |
Volume | 145 |
Pages (from-to) | 256-283 |
Number of pages | 28 |
ISSN | 0891-5849 |
DOIs | |
Publication status | Published - 2019 |
Keywords
- 8-oxo-7,8-dihydro-2′-deoxyguanosine
- 8-oxo-7,8-dihydro-guanosine
- Clinical trials
- Intervention
- Oxidative nucleic acid modifications
- Oxidative stress